Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

A pathway helps maintain long telomeres in both stem and cancer cells.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Further research is needed to develop effective cancer prevention strategies.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Biological therapy boosts the immune system to effectively fight melanoma.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Blocking YAP/TAZ could be a new way to treat skin cancer.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Cedrol may be an effective treatment for colorectal cancer.